Ascendis Pharma A (ASND) Capital Expenditures (QoQ) (2014 - 2024)
Ascendis Pharma A (ASND) Capital Expenditures (QoQ) (2014 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ascendis Pharma A |
2.75 Bn |
2.08 Bn |
268.20 Mn |
| Date | Value |
|---|
| Sep 30, 2024 |
-39.25% |
| Jun 30, 2024 |
-70.36% |
| Mar 31, 2024 |
-418.93% |
| Dec 31, 2023 |
106.38% |
| Sep 30, 2023 |
-119.75% |
| Jun 30, 2023 |
58.48% |
| Mar 31, 2023 |
69.82% |
| Dec 31, 2022 |
-20.99% |
| Sep 30, 2022 |
19.79% |
| Jun 30, 2022 |
7.22% |
| Mar 31, 2022 |
-108.79% |
| Dec 31, 2021 |
465.80% |
| Sep 30, 2021 |
-208.92% |
| Jun 30, 2021 |
11.15% |
| Mar 31, 2021 |
-111.48% |
| Dec 31, 2020 |
842.99% |
| Sep 30, 2020 |
-12.69% |
| Jun 30, 2020 |
25.52% |
| Mar 31, 2020 |
-166.65% |
| Dec 31, 2019 |
831.26% |
